Truist Financial Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective upped by Truist Financial from $22.00 to $24.00 in a research note released on Wednesday morning,Benzinga reports. The firm currently has a buy rating on the real estate investment trust’s stock.

SBRA has been the topic of several other research reports. Robert W. Baird upped their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “neutral” rating in a report on Wednesday. Wells Fargo & Company lifted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Cantor Fitzgerald boosted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Finally, Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $22.25.

Sabra Healthcare REIT Stock Performance

Shares of SBRA opened at $21.98 on Wednesday. The stock has a market capitalization of $5.54 billion, a P/E ratio of 34.89, a P/E/G ratio of 1.64 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $22.55. The company’s fifty day moving average is $19.63 and its two-hundred day moving average is $19.80.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same period last year, the firm earned $0.37 EPS. The company’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts predict that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 5.5%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several hedge funds and other institutional investors have recently modified their holdings of SBRA. Vanguard Group Inc. lifted its position in Sabra Healthcare REIT by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock valued at $671,045,000 after buying an additional 481,231 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of Sabra Healthcare REIT by 0.4% in the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock worth $481,755,000 after acquiring an additional 98,770 shares in the last quarter. Nuveen LLC increased its position in shares of Sabra Healthcare REIT by 28.6% in the fourth quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock worth $138,324,000 after acquiring an additional 1,625,072 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Sabra Healthcare REIT by 2.9% in the 4th quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock valued at $132,949,000 after acquiring an additional 198,118 shares during the period. Finally, Bank of America Corp DE raised its stake in shares of Sabra Healthcare REIT by 9.4% in the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock valued at $97,378,000 after acquiring an additional 447,528 shares during the period. 99.40% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Truist Financial raised its price target on Sabra Healthcare REIT from $22 to $24 and reiterated a buy rating, signaling confidence in further upside. Benzinga
• Positive Sentiment: Citizens JMP lifted its price target from $23 to $25 and maintained a market outperform rating, suggesting analysts see additional room for the stock to climb. Benzinga
• Positive Sentiment: Sabra increased FY 2026 EPS guidance to $1.53-$1.55, above the consensus estimate of $1.50, which supports the case for stronger-than-expected earnings. Business Wire
• Positive Sentiment: The company announced a major portfolio reshaping, including plans to re-tenant properties previously leased to Avamere, which may improve occupancy stability and operational quality over time. TipRanks
• Neutral Sentiment: Zacks noted SBRA was a strong recent mover on heavy volume, but also warned that recent FFO estimate revisions could limit near-term follow-through. Zacks

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.